Christopher Cain, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Cain, Ph.D.
Christopher Cain, Ph.D. is recorded as Board Member at Viridian Therapeutics, Inc.\DE (VRDN). Viridian Therapeutics, Inc.\DE reported in an 8-K filed March 10, 2025 that Christopher Cain, Ph.D. was appointed chairperson of the Nominating and Corporate Governance Committee, effective March 10, 2025. Viridian Therapeutics, Inc.\DE reported in an 8-K filed March 10, 2025 that Christopher Cain, Ph.D. was appointed Class I director, effective March 10, 2025.
“On March 5, 2025, the Board of Directors (the "Board") of Viridian Therapeutics, Inc. (the "Company"), appointed Christopher Cain, Ph.D., the Director of Research at Fairmount Funds Management LLC, to serve as a Class I director of the Company, chairperson of the Nominating and Corporate Governance Committee, and member of the Audit Committee and Science & Technology Committee, effective as of March 10, 2025.”
“On March 5, 2025, the Board of Directors (the "Board") of Viridian Therapeutics, Inc. (the "Company"), appointed Christopher Cain, Ph.D., the Director of Research at Fairmount Funds Management LLC, to serve as a Class I director of the Company, chairperson of the Nominating and Corporate Governance Committee, and member of the Audit Committee and Science & Technology Committee, effective as of March 10, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-03-10–present
-
Current
2025-03-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Viridian Therapeutics, Inc.\DE
Other people whose current roles at this company are on record from its filings.
- Scott Myers CEO, Board Member
- Stephen Mahoney CEO, Board Member
- Tomas Kiselak Chairman
- Seth Harmon CFO
- Jonathan Violin COO
- Lee Rauch COO, Board Member
- Thomas Beetham COO
- Lara Meisner General Counsel
- Kristian Humer Chief Accounting Officer
- Arlene M. Morris Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.